TSE:4502 stock news
This page provides real-time market news, earnings updates, and company announcements related to Takeda Pharmaceutical Co. Ltd. (TSE:4502).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-05 02:03 JST
Yen Continues to Weaken Despite Warnings from Katayama and Bessent
101 finance2026-01-13 08:51:23
Takaichi’s Initial Election Strategy in Japan Shakes Up Yen, Bonds, and Equities
101 finance2026-01-13 08:54:33
On the premier platform for biotechnology, revived enthusiasm faces a critical examination
101 finance2026-01-16 11:51:07
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Finviz2026-02-26 12:03:46
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
Takeda Pharmaceutical and Protagonist Therapeutics Inc (NASDAQ: PTGX) jointly announced that the U.S. Food and Drug Administration (FDA) has officially accepted the New Drug Application (NDA) for their co-developed drug Rusfertide and granted it priority review status.
老虎证券2026-03-02 07:36:04
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
Finviz2026-03-02 13:03:55
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
Takeda Pharmaceutical and Protagonist Therapeutics Inc (NASDAQ: PTGX) jointly announced that the U.S. Food and Drug Administration (FDA) has officially accepted the New Drug Application (NDA) for their co-developed drug Rusfertide and granted it priority review status.
老虎证券2026-03-02 07:36:04
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
Finviz2026-03-02 13:03:55
TSE:4502 stock price change
On the last trading day, TSE:4502 stock closed at 5727.00 JPY, with a price change of -1.16% for the day.
Trade stock perpsTSE:4502 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more